NASDAQ:KMTS
Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd.'s revenue grew 59.0% in fiscal 2026 to $95.1M while operating margin rose to −141.6%, its highest in 3 years. Free cash flow was −$116.6M, −122.6% of revenue, and the diluted share count rose 120.4%.Summary generated from Kestra Medical Technologies, Ltd.'s SEC filings. Latest annual report filed Jul 14, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$95.1M
Revenue growth+59.0%
Revenue, 5-yr CAGRn/a
Gross margin51.4%
Operating margin−141.6%
Net margin−138.4%
ROIC−100.7%
Return on equity−56.6%
Debt / equity0.16
Free cash flow−$116.6M
FCF margin−122.6%
Share count change+120.4%
Financials
| Item | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 28 | 60 | 95 |
| Operating income | −85 | −106 | −135 |
| Net income | −94 | −114 | −132 |
| Free cash flow | −84 | −101 | −117 |
Recent filings
- 4Insider transaction report
Oct 1, 2026 - 4Insider transaction report
Sep 23, 2026 - 10-QQuarterly report for the period ended Jul 31, 2026
Sep 14, 2026 - 8-KResults of operations and financial condition
Sep 14, 2026 - 8-KResults of a shareholder vote
Sep 10, 2026 - DEF 14AProxy statement
Jul 28, 2026 - 10-KAnnual report for the fiscal year ended Apr 30, 2026
Jul 14, 2026 - 8-KEntry into a material agreement
Jul 14, 2026